The diagnostic value of minimally invasive surgery Mammotome in malignant breast tumor

VernacularTitle:Mammotome微创旋切活检术对乳腺恶性肿瘤的临床诊治价值分析
Author: Heng LIU ¹ ; Yi DONG ; Gangyue WANG
Author Information

1. 100006,首都医科大学附属北京妇产医院乳腺科
Keywords: biopsy; breast cancer; minimal invasion
From: Journal of Clinical Surgery 2018;26(5):366-368
CountryChina
Language:Chinese
Abstract: Objective To study the clinical value of minimally invasive surgery Mammotome in diagnosing and treating early breast cancer.Methods The clinical data from 41 cases of breast cancer underwent Mammotome from January 2015 to June 2016,were retrospectively analyzed.Results Patients aged 35~50 years old accounted for the highest proportion in patients with breast cancer underwent mini-mally invasive surgery,and patients aged older than 50 years old of age was on the contrary.The incidence of breast cancer in the upper outer quadrant was significantly higher than the other quadrants.The diame-ter of 83% lesions were no more than 20 mm and 85% of all cases had no axilla lymph node metastasis, which suggested that MMT biopsy had advantage of diagnosing early breast cancer.BI-RADS reported as 4a,but MMT biopsy of malignancy accounted for 71%.All cases had no local recurrence and metastasis in 3-months,6-months and 12-months follow-up.Conclusion Mammotome-biopsy not only removes tumors with minimal invasion,but also is good for early diagnosis and therapy of breast cancer.